30 Mg Octreotide Injection

Name: 30 Mg Octreotide Injection
Brand: NEETCO BIOPHARMA
Price: 14499 INR
Availability: InStock

Price 14499 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

30 Mg Octreotide Injection Specification

Salt Composition
Octreotide 30 mg

Indication
Used to treat acromegaly, severe diarrhea and flushing episodes associated with metastatic carcinoid tumors, and vasoactive intestinal peptide tumors (VIPomas).

Dosage Form
Injection

Enzyme Types
Not applicable (synthetic peptide hormone analogue)

Feature
Long-acting release (LAR) formulation for sustained therapeutic action

Ingredients
Octreotide acetate, sterile vehicle

Application
Subcutaneous or intramuscular administration as per physician guidance

Ph Level
Approximately 4.5 6.5

Physical Color/Texture
Clear, colorless to slightly yellow solution

Fermentation Smell
Odorless

Storage Instructions
Store in refrigerator at 2C to 8C (36F to 46F); do not freeze. Protect from light.

Shelf Life
24 months from manufacturing date

Diluent Provided
Sterile diluent for injection included

Prescription
Prescription only (Rx)

Administration Route
Intramuscular injection

Precautions
Administer under medical supervision; monitor liver and thyroid function as indicated

Usage Category
Hospital use, oncology, endocrinology

Appearance after Reconstitution
Clear, free from visible particles

Contraindications
Known hypersensitivity to octreotide or any component of the formulation

Pack Size
Single vial with solvent for reconstitution

Packaging Type
Glass vial with rubber stopper and flip-off cap

Strength
30 mg/vial

Common Side Effects
Gastrointestinal disturbances, gallstone formation, bradycardia, injection site reactions

Marketed By
As specified on packaging

Regulatory Status
Approved prescription medicine

About 30 Mg Octreotide Injection

Buy Online the in-demand 30 Mg Octreotide Injection, a must-have for hospitals, oncology, and endocrinology uses. This decorated, rarefied formulation comes as a single glass vial with a sterile diluent and is administered via intramuscular injection under medical supervision. Distinguished for treating acromegaly, VIPomas, and severe symptoms in metastatic carcinoid tumors, the long-acting release (LAR) formulation ensures sustained therapeutic effects. Presented in a premium glass vial with a rubber stopper and flip-off cap, this prescription-only product is odorless, clear, and stored refrigerated. Exported, supplied, and distributed from India.

Targeted Therapy for Complex Conditions

30 Mg Octreotide Injection is specifically indicated for the management of acromegaly, metastatic carcinoid tumor-related symptoms, and vasoactive intestinal peptide tumors (VIPomas). Administered intramuscularly or subcutaneously as directed by a physician, this long-acting, clear solution offers consistent, controlled release for sustained therapeutic outcomes. Special features include prescription-only dispensing, careful monitoring of liver and thyroid function, and its distinguished use in advanced hospital settings.

Premium Packaging & Global Dispatch Solutions

With premium glass vial packaging, each 30 Mg Octreotide Injection is securely packed for dispatch and export. Supplied with a sterile diluent, rubber stopper, and flip-off cap, it ensures product integrity. Packing & Dispatch is carried out meticulously for hospital supply. Quotation for bulk or sample orders is available upon request. Our products are mainly exported to international markets from India, meeting regulatory standards for global distribution.

FAQ's of 30 Mg Octreotide Injection:

Q: How should 30 Mg Octreotide Injection be administered?

A: 30 Mg Octreotide Injection should be administered via intramuscular or subcutaneous injection, strictly under the supervision and direction of a qualified healthcare professional.

Q: What are the indications for using this distinguished injection?

A: This injection is indicated for the treatment of acromegaly, severe diarrhea and flushing episodes associated with metastatic carcinoid tumors, and vasoactive intestinal peptide tumors (VIPomas).

Q: When is the use of this product contraindicated?

A: 30 Mg Octreotide Injection is contraindicated in patients with known hypersensitivity to octreotide or any component of the formulation.

Q: What special precautions should be followed during usage?

A: It is essential to monitor liver and thyroid function regularly while using this injection, as recommended by your physician. Administration should always be under strict medical supervision.

Q: Where should the injection be stored for maximum efficacy?

A: Store the injection in a refrigerator at 2C to 8C (36F to 46F), protect it from light, and do not freeze. Ensure it is used before the end of its 24-month shelf life.